Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Wellnex Life's share price for the quarter that ended in Dec. 2025 was A$0.094. Wellnex Life's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 69.96 Mil. Therefore, Wellnex Life's market cap for the quarter that ended in Dec. 2025 was A$6.58 Mil.
Wellnex Life's quarterly market cap
declined
from Dec. 2024 (A$20.14 Mil) to Jun. 2025 (A$17.96 Mil) and
declined
from Jun. 2025 (A$17.96 Mil) to Dec. 2025 (A$6.58 Mil).
Wellnex Life's annual market cap
increased
from Jun. 2023 (A$22.20 Mil) to Jun. 2024 (A$32.24 Mil) but then
declined
from Jun. 2024 (A$32.24 Mil) to Jun. 2025 (A$17.96 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Wellnex Life's Enterprise Value for Today is A$17.46 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Wellnex Life Market Cap Related Terms
Wellnex Life Market Cap Historical Data
* Premium members only.
The historical data trend for Wellnex Life's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Wellnex Life's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wellnex Life Market Cap vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Wellnex Life's Market Cap distribution charts can be found below:
* The bar in red indicates where Wellnex Life's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Wellnex Life's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wellnex Life (ASX:WNX) has a Market Cap of A$8.40 Mil as of Aug. 10, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Wellnex Life and its competitors. According to the industry distribution chart, Wellnex Life ranks #1843 out of 2036 companies in the Consumer Packaged Goods industry, placing it in the top 90.5%.
Is Wellnex Life's Market Cap too high?
Wellnex Life's current Market Cap is A$8.40 Mil. Based on the distribution chart, Wellnex Life ranks #1843 out of 2036 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Wellnex Life has a GF Score™ of 26/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Wellnex Life's Market Cap compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Wellnex Life ranks #1843 out of 2036 companies for Market Cap. This places Wellnex Life in the lower half of its industry. The industry median Market Cap is 107.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Consumer Packaged Goods company?
The median Market Cap among Consumer Packaged Goods companies is 107.90, based on 2,036 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Wellnex Life and its competitors. For the Consumer Packaged Goods industry, the median Market Cap is 107.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wellnex Life's current Market Cap is A$8.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellnex Life stock overvalued right now?
Based on GuruFocus' analysis, Wellnex Life (ASX:WNX) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.36, compared to a current price of A$0.12 — trading 68.1% below its estimated fair value. The current Market Cap is A$8.40 Mil. Wellnex Life's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Wellnex Life (ASX:WNX), the current Market Cap is A$8.40 Mil as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wellnex Life (ASX:WNX) Overvalued in 2026?
Based on GuruFocus' analysis, Wellnex Life stock appears to be undervalued.
The current stock price of A$0.12 is trading 68.1% below its estimated GF Value™ of A$0.36.
GuruFocus considers Wellnex Life to be Possible Value Trap.
Key valuation signals for ASX:WNX:
Market Cap: A$8.40 Mil
GF Value™: A$0.36 vs. price of A$0.12 (68.1% below fair value)
No single metric tells the full story. See the ASX:WNX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wellnex Life Ltd is a consumer healthcare company focused on developing, licensing, marketing, and distributing healthcare and pharmaceutical products. These products are available mainly through Australian retailers and wholesalers, including Coles, Woolworths, Chemist Warehouse, Sigma, and Symbion. The group's offerings include caffeine energy liquid capsules, multivitamins, pain relief creams and sprays, sleep aids, toothpaste, over-the-counter medicines, and medical cannabis products, among others. Its brands include Pharmacy Own, Wellness Life, Mr. Bright, Pain Away, Nighty Night, Wakey Wakey, and Wagner Health Liquigesic. Geographically, the majority of the group's revenue comes from Australia, with additional contributions from the United Kingdom and New Zealand.
26GF Score
Get the complete analysis for ASX:WNX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:WNX has been successfully added to your 
